DP

Dejan Pavlovic

Executive Director, Patient Safety TA Oncology at AstraZeneca

Dejan Pavlovic is an experienced executive in patient safety within the pharmaceutical industry, currently serving as Executive Director of Patient Safety in Oncology at AstraZeneca since October 2015, after holding the position of Senior Medical Director in Patient Safety. Prior experience includes serving as Medical Director of Patient Safety at MedImmune from October 2011 to October 2015, and leading drug safety efforts at UCB Biosciences and UCB from November 2005 to October 2011. Dejan Pavlovic holds a PhD in Medicine from Vrije Universiteit Brussel, a Master in Industrial Management from EHSAL Business School, a Master in Medical and Pharmaceutical Research from Vrije Universiteit Brussel, and an MD from Univerzitet u Nišu.

Links

Previous companies

UCB logo

Timeline

  • Executive Director, Patient Safety TA Oncology

    June, 2017 - present

  • Senior Medical Director Patient Safety

    October, 2015